Search review questions

Time to next/working arch wire · People receiving orthodontic treatment with fixed appliances (upper and/or lower full arch)

Salivary S. mutans level · Humans with salivary bacteria measured · Overall

Dental caries prevalence · Adult residents of slums and non-slum urban settings of LMICs · Cross-sectional

Positive predictive value · Children and adults with primary or permanent dentition undergoing dental caries assessment · Cross-sectional diagnostic accuracy (index test vs reference standard, in-vivo), Overall (studies reporting PPV; narrative synthesis)

Oral cancer (OC) · Sensitivity analysis: excluding Moraes et al. [34]

Adverse effects · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF)

Salivary pH · Children and/or adolescents (<18 years) without background systemic disease · follow-up: mean 1.1 months, Overall (all presentations pooled)

Adverse effects · Adults with a symptomatic necrotic tooth or localised acute apical abscess (no signs of spreading infection or… · 3 days

Self-esteem (Oral Aesthetic Subjective Impact Score, OASIS) · Children and adolescents (aged 16 years or younger) with prominent lower front teeth (Class III malocclusion) · 3-year follow-up

Pathogenic bacteria / plaque composition around brackets (fewer pathogenic bacteria with flash-free vs APC; comparable plaque quantity)

Frequency of joint noise · People with temporomandibular disorders (TMD) · Short term (mean 10 weeks), Myofascial pain TMD

Maximal mouth opening (interincisal distance) · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF) · 3 to 6 months

Congruence between informed values and choice ‐ all studies Based on the proportion of participants who made a decision that aligned with what was most important to them. Assessed soon after exposure to the decision aid. · adults considering treatment or screening decisions

Knowledge ‐ all studies Standardized on a scale from 0 (no knowledge) to 100 (perfect knowledge). Assessed soon after exposure to the decision aid. · adults considering treatment or screening decisions

Accurate risk perceptions ‐ all studies Based on the accuracy of perceived outcome probabilities according to the percentage of individuals whose judgments corresponded to the scientific evidence about the chances of an outcome for similar people.... · adults considering treatment or screening decisions

Decisional conflict: uninformed subscale ‐ all studies Standardized on a scale from 0 (informed) to 100 (uninformed). Assessed soon after exposure to the decision aid. · adults considering treatment or screening decisions

Decisional conflict: unclear about personal values subscale ‐ all studies Standardized on a scale from 0 (clear) to 100 (unclear). Assessed soon after exposure to the decision aid. · adults considering treatment or screening decisions

Participation in decision‐making: clinician‐controlled decision‐making ‐ all studies Based on the proportion of participants who indicated a passive role in decision‐making where the decision was primarily made by the clinician. Assessed soon afte... · adults considering treatment or screening decisions

Adverse events: decision regret ‐ all studies Standardized on a scale from 0 (no regret) to 100 (high regret). Assessed weeks to months after the decision is made. · adults considering treatment or screening decisions

Clinical improvement ‐ Long‐term improvement: > 3 months · people with carpal tunnel syndrome

Function ‐ Long‐term improvement: > 3 months · people with carpal tunnel syndrome

Pain (VAS) ‐ Long‐term improvement: > 3 monthsScale: 0 to 100, higher is worse · people with carpal tunnel syndrome

Health‐related quality of life ‐ Long‐term improvement: > 3 months · people with carpal tunnel syndrome

Adverse effects · people with carpal tunnel syndrome

Need for surgery or secondary surgery during · people with carpal tunnel syndrome

Symptoms (Boston CTS questionnaire) ‐ Long‐term improvement: > 3 monthsScale: 1 to 5, higher is worse · people with carpal tunnel syndrome

Function (Boston CTS questionnaire) ‐ Long‐term improvement: > 3 monthsScale: 1 to 5, higher is worse · people with carpal tunnel syndrome

Pain ‐ Long‐term improvement: > 3 months · people with carpal tunnel syndrome

Health‐related quality of life (EQ‐5D) ‐ Long‐term improvement: > 3 months Scale: 0 to 1, higher is better · people with carpal tunnel syndrome

Adverse effects · people with carpal tunnel syndrome

Need for surgery or secondary surgery during · people with carpal tunnel syndrome

Clinical improvement ‐ Long‐term improvement: > 3 months · people with carpal tunnel syndrome

Symptoms ‐ Long‐term improvement: > 3 months · people with carpal tunnel syndrome

Significant improvement in disability within 6 weeks · people with CIDP

Change in mean disability score on Rankin scale · patients with CIDP

Change in mean disability score at 24 weeks or later · patients with CIDP

Serious adverse events · patients with CIDP

Significant improvement in disability within 6 weeks · people with CIDP

Change in mean disability score on Rankin scale · people with CIDP

Change in mean disability score at 24 weeks or later · people with CIDP

Serious adverse events · people with CIDP

Change in mean disability score on Rankin scale · people with CIDP

Change in mean disability score at 24 weeks or later · people with CIDP

Serious adverse events · people with CIDP

Significant improvement in disability within 6 weeks · people with CIDP

Change in mean disability score on Rankin scale · people with CIDP

Change in mean disability score at 24 weeks or later · people with CIDP

Serious adverse events · people with CIDP

Significant improvement in disability within 6 weeks · patients with CIDP

Quit at longest · individuals who smoke cigarettes and are admitted to a hospital for medical or surgical care